Allakos, Inc. (NASDAQ:ALLK)
About the company
Allakos, Inc. engages in the development of therapeutic antibodies. Its primary product is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis. The company was founded by Christopher Bebbington, Nenad Tomasevic, Bruce S. Bochner, and Robert Schleimer in 2012 and is headquartered in Redwood, CA.
Stock price
Gross Margin (in %)
Operating Margin (in %)
Net Margin (in %)
Dividend Yield (in %)
Revenues - Income - Cash Flows (in USD Million)
Margins (in %)
Return on capital (in %)
Ratios (in %)
Industry margins
Industry workforces
Industry revenues and market cap
Industry ratios
90-days Stock Price Forecast (in %)
Industry peers
| Name | Ticker | Market capitalization (in USD Million) | Revenues (in USD Million) | Price/Book | Price/Earning | Net margin (in %) |
|---|---|---|---|---|---|---|
| Johnson & Johnson | JNJ | 381445.74 | 82729.00 | 6.13 | 22.23 | 20.75 |
| Merck & Co., Inc. | MRK | 196786.55 | 48081.00 | 7.39 | 19.42 | 21.10 |
| Pfizer Inc. | PFE | 188747.85 | 50660.00 | 2.86 | 11.95 | 31.17 |
| Eli Lilly & Co. | LLY | 151075.27 | 23087.00 | 51.27 | 26.63 | 23.97 |
| AbbVie, Inc. | ABBV | 145342.96 | 34057.00 | -23.26 | 17.33 | 24.65 |
| Bristol Myers Squibb Co. | BMY | 108491.37 | 31006.00 | 2.63 | 92.24 | 3.08 |
| Repligen Corp. | RGEN | 6389.28 | 286.00 | 6.13 | 278.40 | 8.11 |
| Reata Pharmaceuticals, Inc. | RETA | 4839.72 | 20.00 | 22.93 | -15.57 | -150.30 |
| Nektar Therapeutics | NKTR | 4363.04 | 137.00 | 3.41 | -9.50 | -335.62 |
| Biohaven Pharmaceutical Holding Co. Ltd. | BHVN | 3946.28 | 1.00 | 36.49 | -6.04 | None |
| Allakos, Inc. | ALLK | 3152.76 | None | 6.84 | -33.71 | None |
| ADC Therapeutics SA | ADCT | 2565.54 | 2.00 | 30.26 | -22.00 | None |
| Karuna Therapeutics, Inc. | KRTX | 2485.08 | None | 6.49 | -61.27 | None |
| OPKO Health, Inc. | OPK | 2448.18 | 891.00 | 1.74 | -8.37 | -32.92 |
| Turning Point Therapeutics, Inc. | TPTX | 2259.72 | None | 6.80 | -18.91 | None |
| IGM Biosciences, Inc. | IGMS | 2221.15 | None | 9.79 | -40.94 | None |
| Ra Pharmaceuticals, Inc. | RARX | 2111.78 | 3.00 | 8.68 | -20.78 | -585.71 |
| Apellis Pharmaceuticals, Inc. | APLS | 2094.84 | None | 9.25 | -5.02 | None |
| Springworks Therapeutics, Inc. | SWTX | 1695.06 | None | 5.51 | -27.19 | None |
| Principia Biopharma, Inc. | PRNB | 1578.64 | 30.00 | 5.62 | -22.46 | -242.01 |
| Y-mAbs Therapeutics, Inc. | YMAB | 1495.17 | None | 9.16 | -16.23 | None |
| Zymeworks, Inc. | ZYME | 1473.78 | 26.00 | 3.06 | -8.69 | -629.37 |
| Tricida, Inc. | TCDA | 1300.46 | None | 6.69 | -6.16 | None |
| Akcea Therapeutics, Inc. | AKCA | 1289.13 | 341.00 | 2.65 | -45.83 | -8.59 |
| Kiniksa Pharmaceuticals Ltd. | KNSA | 1267.20 | None | 6.56 | -10.47 | None |
| Akero Therapeutics, Inc. | AKRO | 1138.62 | None | 9.51 | -22.44 | None |
| Odonate Therapeutics, Inc. | ODT | 1127.52 | None | 9.24 | -10.02 | None |
| Arcutis Biotherapeutics, Inc. | ARQT | 1074.85 | None | 4.58 | -17.19 | None |
| Phibro Animal Health Corp. | PAHC | 1060.26 | 818.00 | 5.35 | 28.73 | 4.49 |
| Athenex, Inc. | ATNX | 1014.78 | 123.00 | 6.22 | -9.43 | -87.86 |
| Constellation Pharmaceuticals, Inc. | CNST | 932.16 | None | 4.39 | -10.04 | None |
| G1 Therapeutics, Inc. | GTHX | 811.30 | 1.00 | 3.51 | -6.19 | None |
| Gossamer Bio, Inc. | GOSS | 809.47 | None | 3.28 | -4.07 | None |
| Phathom Pharmaceuticals, Inc. | PHAT | 750.75 | None | 4.17 | -2.76 | None |
| Quanterix Corp. | QTRX | 742.50 | 60.00 | 6.55 | -16.98 | -71.52 |
| Krystal Biotech, Inc. | KRYS | 721.31 | None | 4.21 | -34.78 | None |
| Oric Pharmaceuticals, Inc. | ORIC | 687.96 | None | -7.47 | -22.75 | None |
| Applied Therapeutics, Inc. | APLT | 686.84 | 14.00 | 4.43 | -13.94 | -19.41 |
| Provention Bio, Inc. | PRVB | 669.94 | None | 10.60 | -15.13 | None |
| Provention Bio, Inc. | PRVB | 651.88 | None | 10.31 | -14.72 | None |
| Aprea Therapeutics, Inc. | APRE | 647.22 | None | 5.73 | -19.14 | None |
| Arcturus Therapeutics Holdings, Inc. | ARCT | 632.06 | 19.00 | 58.58 | -22.72 | -151.34 |
| Amneal Pharmaceuticals, Inc. | AMRX | 617.87 | 1679.00 | 4.25 | -2.84 | -11.85 |
| Keros Therapeutics, Inc. | KROS | 601.74 | 8.00 | -27.18 | -28.33 | -285.35 |
| Oyster Point Pharma, Inc. | OYST | 546.00 | None | 5.49 | -9.49 | None |
| Mirum Pharmaceuticals, Inc. | MIRM | 491.75 | None | 3.20 | -7.26 | None |
| SIGA Technologies, Inc. | SIGA | 467.40 | 19.00 | 5.23 | -23.75 | -94.00 |
| 89bio, Inc. | ETNB | 457.80 | None | 5.65 | -7.09 | None |
| Fulcrum Therapeutics, Inc. | FULC | 444.13 | 1.00 | 7.48 | -6.44 | None |
| Osmotica Pharmaceuticals Plc | OSMT | 442.80 | 232.00 | 3.36 | -1.61 | -115.44 |
| Biospecifics Technologies Corp. | BSTC | 442.54 | 40.00 | 3.59 | 18.93 | 61.80 |
| Satsuma Pharmaceuticals, Inc. | STSA | 441.32 | None | 4.34 | -12.13 | None |
| Imara, Inc. | IMRA | 395.33 | None | 3.82 | -11.23 | None |
| DURECT Corp. | DRRX | 394.04 | 28.00 | 30.26 | -16.30 | -82.94 |
| TCR2 Therapeutics, Inc. | TCRR | 383.04 | None | 2.62 | -38.00 | None |
| Kala Pharmaceuticals, Inc. | KALA | 383.04 | 6.00 | 4.19 | -4.17 | None |
| Relmada Therapeutics, Inc. | RLMD | 380.88 | 0.00 | 5.68 | -31.82 | -877.66 |
| Crinetics Pharmaceuticals, Inc. | CRNX | 376.08 | 1.00 | 4.75 | -6.45 | -447.78 |
| Ocular Therapeutix, Inc. | OCUL | 357.12 | 6.00 | -43.76 | -3.90 | None |
| Ovid Therapeutics, Inc. | OVID | 349.65 | None | 8.27 | -5.36 | None |
| Aeglea Biotherapeutics, Inc. | AGLE | 303.27 | 4.00 | 9.57 | -3.78 | -523.27 |
| Urovant Sciences Ltd. | UROV | 285.60 | None | -5.06 | -1.98 | None |
| IDEAYA Biosciences, Inc. | IDYA | 270.40 | None | 4.11 | -6.20 | None |
| Spero Therapeutics, Inc. | SPRO | 268.28 | 12.00 | 3.53 | -3.30 | -656.72 |
| HOOKIPA Pharma, Inc. | HOOK | 267.80 | 13.00 | 2.42 | -5.92 | -333.02 |
| Gritstone Oncology, Inc. | GRTS | 255.60 | 4.00 | 2.29 | -2.45 | None |
| AMAG Pharmaceuticals, Inc. | AMAG | 240.04 | 321.00 | 0.92 | -0.65 | -115.05 |
| Lannett Co., Inc. | LCI | 234.84 | 542.00 | 0.80 | -7.72 | -5.77 |
| KalVista Pharmaceuticals, Inc. | KALV | 224.64 | 12.00 | 2.48 | -6.93 | -263.38 |
| Verrica Pharmaceuticals, Inc. | VRCA | 219.00 | None | 4.00 | -7.18 | None |
| Kaleido Biosciences, Inc. | KLDO | 207.90 | None | 7.37 | -2.84 | None |
| Sutro Biopharma, Inc. | STRO | 200.79 | 41.00 | 3.81 | -3.29 | -148.06 |
| Veru, Inc. | VERU | 200.20 | 39.00 | 6.70 | -20.53 | -25.53 |
| Galera Therapeutics, Inc. | GRTX | 187.25 | None | 3.50 | -2.85 | None |
| LogicBio Therapeutics, Inc. | LOGC | 175.03 | 1.00 | 5.28 | -4.11 | None |
| Protara Therapeutics, Inc. | TARA | 173.10 | None | 2.60 | -11.23 | None |
| Liquidia Technologies, Inc. | LQDA | 166.10 | 8.00 | 13.02 | -3.37 | -602.17 |
| Avenue Therapeutics, Inc. | ATXI | 156.00 | 532.00 | 28.68 | -10.71 | 26.69 |
| Cyclerion Therapeutics, Inc. | CYCN | 153.49 | 6.00 | 1.93 | -1.48 | None |
| Corvus Pharmaceuticals, Inc. | CRVS | 147.45 | None | 2.36 | -3.12 | None |
| Lyra Therapeutics, Inc. | LYRA | 145.68 | 1.00 | -1.24 | -8.73 | -491.16 |
| Tyme Technologies, Inc. | TYME | 144.90 | None | 8.40 | -6.63 | None |
| scPharmaceuticals, Inc. | SCPH | 143.36 | 119.00 | 3.66 | -4.57 | -27.05 |
| Evelo Biosciences, Inc. | EVLO | 140.80 | None | 5.18 | -1.61 | None |
| PhaseBio Pharmaceuticals, Inc. | PHAS | 134.85 | 2.00 | 2.50 | -2.82 | None |
| Mustang Bio, Inc. | MBIO | 125.60 | None | 2.93 | -2.55 | None |
| Aquestive Therapeutics, Inc. | AQST | 123.48 | 49.00 | -7.11 | -1.76 | -139.64 |
| Harrow Health, Inc. | HROW | 122.46 | 51.00 | 7.85 | -4.96 | -47.54 |
| TFF Pharmaceuticals, Inc. | TFFP | 117.80 | None | 4.56 | -3.04 | None |
| Immunic, Inc. | IMUX | 117.40 | None | 3.45 | -53.36 | None |
| NeuBase Therapeutics, Inc. | NBSE | 117.04 | None | 49.18 | -2.62 | None |
| Ayala Pharmaceuticals, Inc. | AYLA | 112.20 | 3.00 | -2.64 | -5.44 | -679.19 |
| Evolus, Inc. | EOLS | 100.50 | 45.00 | 1.80 | -0.99 | -217.51 |
| Eton Pharmaceuticals, Inc. | ETON | 94.32 | 1.00 | 10.27 | -4.72 | None |
| Milestone Pharmaceuticals, Inc. | MIST | 93.86 | None | 0.93 | -1.51 | None |
| Trevi Therapeutics, Inc. | TRVI | 93.60 | None | 1.98 | -3.19 | None |
| EyePoint Pharmaceuticals, Inc. | EYPT | 78.49 | 26.00 | 5.54 | -1.60 | -196.30 |
| Checkpoint Therapeutics, Inc. | CKPT | 76.80 | 2.00 | 6.62 | -3.31 | -949.53 |
| Clearside Biomedical, Inc. | CLSD | 72.57 | 6.00 | 9.32 | -4.12 | -293.61 |
| Xeris Pharmaceuticals, Inc. | XERS | 72.24 | 4.00 | 3.58 | -0.56 | None |
| Navidea Biopharmaceuticals, Inc. | NAVB | 68.17 | 1.00 | -50.13 | -6.17 | -65.13 |
| Baudax Bio, Inc. | BXRX | 63.54 | None | -1.73 | -0.91 | None |
| BiomX, Inc. | PHGE | 60.06 | None | 1.58 | -1.40 | None |
| Genprex, Inc. | GNPX | 59.60 | None | 5.06 | -4.36 | None |
| Assertio Therapeutics, Inc. | ASRT | 57.60 | 192.00 | 1.00 | -0.35 | -83.99 |
| Aridis Pharmaceuticals, Inc. | ARDS | 55.44 | 1.00 | -22.81 | -1.90 | -851.00 |
| Aerpio Pharmaceuticals, Inc. | ARPO | 54.12 | 20.00 | 1.63 | -2.87 | -51.58 |
| Menlo Therapeutics, Inc. | MNLO | 48.72 | 2.00 | 4.10 | -0.52 | -483.51 |
| Eyenovia, Inc. | EYEN | 45.12 | None | 4.55 | -2.20 | None |
| Edesa Biotech, Inc. | EDSA | 44.01 | 0.00 | 6.27 | -0.46 | -395.23 |
| Annovis Bio, Inc. | ANVS | 42.49 | None | 3.89 | -33.72 | None |
| Moleculin Biotech, Inc. | MBRX | 40.48 | None | 3.52 | -4.40 | None |
| Acer Therapeutics, Inc. | ACER | 36.30 | 3.00 | 2.65 | -1.39 | -274.69 |
| Akari Therapeutics Plc | AKTX | 36.18 | None | -33.50 | -2.01 | None |
| Citius Pharmaceuticals, Inc. | CTXR | 34.83 | None | 2.58 | -2.02 | None |
| AgeX Therapeutics, Inc. | AGE | 33.82 | 2.00 | -44.50 | -2.78 | -658.11 |
| Oncternal Therapeutics, Inc. | ONCT | 33.67 | 3.00 | 4.32 | -1.34 | -225.89 |
| Mannatech, Inc. | MTEX | 33.40 | 156.00 | 1.41 | 7.52 | 3.45 |
| Allena Pharmaceuticals, Inc. | ALNA | 33.35 | None | 4.39 | -0.77 | None |
| Aileron Therapeutics, Inc. | ALRN | 30.80 | None | 4.23 | -1.16 | None |
| Adamis Pharmaceuticals Corp. | ADMP | 30.16 | 22.00 | 1.16 | -1.02 | -140.33 |
| CNS Pharmaceuticals, Inc. | CNSP | 29.28 | None | 5.08 | -5.38 | None |
| Hoth Therapeutics, Inc. | HOTH | 25.40 | None | 7.06 | -2.82 | None |
| Millendo Therapeutics, Inc. | MLND | 25.20 | 0.00 | 0.59 | -0.54 | None |
| Spring Bank Pharmaceuticals, Inc. | SBPH | 24.77 | 0.00 | 0.94 | -0.95 | None |
| Akorn, Inc. | AKRX | 22.68 | 721.00 | -1.20 | -0.06 | -55.64 |
| Daré Bioscience, Inc. | DARE | 19.76 | 1.00 | 8.67 | -1.18 | None |
| ProPhase Labs, Inc. | PRPH | 16.92 | 9.00 | 1.53 | -5.64 | -31.15 |
| Adial Pharmaceuticals, Inc. | ADIL | 14.80 | None | 3.61 | -1.95 | None |
| Teligent, Inc. | TLGT | 14.40 | 60.00 | -0.49 | -0.36 | -71.80 |
| Teligent, Inc. | TLGT | 14.40 | 60.00 | -0.49 | -0.36 | -71.80 |
| Novan, Inc. | NOVN | 14.38 | 5.00 | -3.31 | -0.46 | -602.34 |
| PDS Biotechnology Corp. | PDSB | 13.93 | None | 1.54 | -0.55 | None |
| Titan Pharmaceuticals, Inc. | TTNP | 12.07 | 4.00 | 5.03 | -0.67 | -437.91 |
| Novus Therapeutics, Inc. | NVUS | 8.01 | None | 0.69 | -0.38 | None |
| Brickell Biotech, Inc. | BBI | 4.68 | 5.00 | 1.53 | -0.06 | -432.19 |
| BioStar Pharmaceuticals, Inc. | BSPM | 0.21 | 0.00 | 0.01 | 0.10 | 294.01 |
Latest insider transactions
| Date | Role | Name | Transaction | Quantity | Quantity Owned After |
|---|
Hedge Funds Dropped The Ball On Allakos Inc. (ALLK)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds ...
Allakos Inc
Allakos Inc. operates as a clinical stage bio-technology company. The Company discovers and develops therapeutic antibodies for the treatment of allergic, inflammatory, and proliferative diseases.
Allakos Inc (NASDAQ:ALLK) Receives $65.00 Average Target Price from Brokerages
Shares of Allakos Inc (NASDAQ:ALLK) have received a consensus rating of “Hold” from the six brokerages that are covering the ...
Allakos (NASDAQ:ALLK) Stock Rating Lowered by BidaskClub
Allakos (NASDAQ:ALLK) was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research ...
Allakos (NASDAQ:ALLK) Downgraded by BidaskClub to Buy
Allakos stock has undergone multiple analysts rating changes in the recent past. Allakos Downgraded by BidaskClub on ...
NASDAQ: ALLK Long Term Investor Notice: Investigation of Potential Wrongdoing at Allakos Inc.
An investigation on behalf of current long term investors in Allakos Inc. (NASDAQ: ALLK) shares over possible breaches of fiduciary duty by certain officers and directors was announced and NASDAQ ...
ALLK Crosses Above Key Moving Average Level
In trading on Tuesday, shares of Allakos Inc (Symbol: ALLK) crossed above their 200 day moving average of $75.36, changing hands as high as $75.98 per share. Allakos Inc shares are currently ...